NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3944 participants.
Also called NCT05638867
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,944 participants
- Registry
-
NCT05638867
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT05638867. Randomized; single masking; primary purpose treatment. Start 2023-11-25 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Aspirin + Clopidogrel + Rivaroxaban
- Intervention (Drug)
- Aspirin + Clopidogrel
- Lead sponsor
- China National Center for Cardiovascular Diseases
Record details
- Record id
cardio:ct-nct05638867- Content hash
507dc80807dce67e56ab7544f20bc87cf8e56933d4c20ea4f52995570373d658